◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
华恒生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Dec 31, 2025FY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013FY 2012Dec 31, 2012
+Revenue 2.9B 2.2B 1.9B 1.4B 954.0M 487.0M 491.0M 421.0M 383.0M 311.0M 253.0M 225.0M 173.0M 86.7M
Revenue Growth % 31.4% 12.4% 36.6% 48.7% 95.9% -0.8% 16.6% 9.9% 23.2% 22.9% 12.4% 30.1% 99.6% --
Total Revenue 2.9B 2.2B 1.9B 1.4B 954.0M 487.0M 491.0M 421.0M 383.0M 311.0M 253.0M 225.0M 173.0M 86.7M
Cost Of Revenue 2.3B 1.6B 1.2B 870.0M 646.0M 287.0M 265.0M 254.0M 250.0M 193.0M 170.0M 151.0M 133.0M 75.6M
+Gross Profit 609.0M 543.0M 785.0M 549.0M 308.0M 200.0M 226.0M 167.0M 133.0M 118.0M 83.0M 74.0M 40.0M 11.1M
Gross Margin % 21.3% 24.9% 40.5% 38.7% 32.3% 41.1% 46.0% 39.7% 34.7% 37.9% 32.8% 32.9% 23.1% 12.8%
Total Operating Cost 2.8B 2.0B 1.5B 1.1B 790.0M 376.0M 355.0M 343.0M 317.0M 243.0M 210.0M 207.0M 164.0M 95.2M
Selling Expenses 71.5M 63.6M 50.4M 29.3M 15.3M 7.0M 16.7M 14.3M 11.7M 9.8M 7.4M 8.8M 5.4M 3.7M
Admin Expenses 208.0M 158.0M 122.0M 113.0M 64.7M 35.8M 33.1M 44.8M 21.0M 36.2M 26.4M 41.3M 17.2M 7.7M
Rd Expenses 151.0M 124.0M 109.0M 78.6M 52.8M 30.1M 30.0M 21.7M 19.8M -- -- -- -- --
Finance Expenses 43.7M 22.6M 3.1M -6.7M -207,300 7.2M 2.9M 3.7M 9.5M 1.2M 1.6M 4.7M 9.1M 6.4M
+Operating Income 130.0M 199.0M 511.0M 342.0M 186.0M 132.0M 146.0M 84.5M 73.0M 68.0M 45.9M 22.2M 12.1M -5.9M
Operating Margin % 4.5% 9.1% 26.4% 24.1% 19.5% 27.1% 29.7% 20.1% 19.1% 21.9% 18.2% 9.8% 7.0% -6.9%
Non Operating Income 677,100 3.4M 1.6M 6.4M 6.8M 8.9M 2.2M 2.7M 1.9M 5.4M 4.2M 3.9M 1.7M 1.9M
Non Operating Expenses 4.8M 1.3M 6.2M 5.5M 2.4M 1.3M 2.4M 660,800 770,500 214,200 244,100 161,900 160,100 76,700
Investment Income -915,400 853,100 2.9M 8.2M 5.5M -- -- -- -- -- 2.5M 3.9M 3.2M 2.6M
Fair Value Change Income -- -- -313,200 -749,400 1.1M -- -- -- -- -- -- -- -- --
Asset Disposal Income 122,600 -64,200 -5,200 23,500 -66,400 15,700 9,500 -- -- -- -- -- -- --
Asset Impairment Loss 13.7M 3.2M 2.9M 53,000 6.0M 2.9M 154,200 360,200 703,300 522,400 2.4M -187,300 -510,300 1.6M
Other Income 26.9M 39.7M 21.1M 10.7M 16.0M 21.1M 10.1M 6.6M 7.1M -- -- -- -- --
Income Before Tax 126.0M 201.0M 506.0M 343.0M 191.0M 140.0M 146.0M 86.5M 74.1M 73.2M 49.9M 25.9M 13.7M -4.1M
Income Tax 1.7M 16.8M 59.7M 23.6M 22.6M 18.8M 19.4M 11.0M 9.3M 11.4M 7.1M 2.9M 1.0M -319,000
+Net Income 124.0M 185.0M 447.0M 319.0M 168.0M 121.0M 126.0M 75.5M 64.9M 61.8M 42.8M 23.0M 12.7M -3.8M
Net Margin % 4.3% 8.5% 23.1% 22.5% 17.6% 24.8% 25.7% 17.9% 16.9% 19.9% 16.9% 10.2% 7.3% -4.4%
Net Income Attributable 132.0M 190.0M 449.0M 320.0M 168.0M 121.0M 126.0M 75.5M 64.9M 61.8M 42.8M 23.0M 13.0M -3.8M
Minority Interest -8.6M -5.0M -2.5M -687,900 -- -- -- -- -- -- -- -- -345,300 --
Eps Basic 0.53 0.82 1.96 2.04 1.70 1.50 1.56 0.94 0.81 1.35 0.94 0.73 1.30 --
Eps Diluted 0.53 0.82 1.96 2.04 1.70 1.50 1.56 0.94 0.81 1.35 0.94 0.73 1.30 --
Line ItemFY 2025Dec 31, 2025FY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013FY 2012Dec 31, 2012
Cash And Equivalents 284.0M 423.0M 353.0M 147.0M 122.0M 62.2M 54.5M 62.1M 24.1M 53.1M 41.3M 24.0M 28.8M 27.8M
Trading Financial Assets -- -- -- 200.0M 341.0M -- -- -- -- -- -- -- -- --
Accounts Receivable 271.0M 284.0M 246.0M 260.0M 176.0M 88.5M 46.5M 63.5M 57.1M 54.5M 47.4M 20.1M 28.4M 9.9M
Notes Receivable 120.0M 56.4M 58.4M 60.1M 35.3M 28.8M 19.4M 24.9M 20.7M 3.1M 4.6M 1.2M 2.1M 1.3M
Notes And Accounts Receivable 392.0M 340.0M 304.0M 321.0M 211.0M 117.0M 65.9M 88.4M 77.9M 57.6M 52.0M 21.3M 30.5M 11.1M
Prepayments 48.0M 26.5M 29.2M 15.9M 33.8M 8.3M 700,500 3.3M 2.0M 3.0M 793,700 627,400 892,700 4.1M
Inventory 532.0M 407.0M 226.0M 136.0M 106.0M 47.1M 55.5M 35.7M 24.7M 29.8M 9.5M 22.1M 17.3M 9.6M
Total Current Assets 1.5B 1.4B 1.1B 863.0M 853.0M 262.0M 186.0M 199.0M 133.0M 149.0M 108.0M 72.4M 80.6M 82.5M
Long Term Equity Investment 5.1M 6.9M -- -- -- -- -- -- -- -- -- 18.0M 16.1M 10.0M
Fixed Assets 2.7B 1.6B 1.1B 763.0M 463.0M 390.0M 293.0M 265.0M 200.0M 186.0M 86.7M 61.8M 59.1M 26.6M
Fixed Assets Total 2.7B 1.6B 1.1B 763.0M 463.0M 390.0M 293.0M 265.0M 200.0M 186.0M 86.7M 61.8M 59.1M 26.6M
Construction In Progress 1.2B 1.6B 1.5B 185.0M 63.3M 20.0M 14.0M 39.0M 34.2M 15.1M 70.0M 12.6M 2.3M 1.7M
Construction In Progress Total 1.2B 1.6B 1.5B 189.0M 65.3M 21.2M 14.5M 39.0M 34.7M 15.1M 70.0M 12.6M 2.3M 1.7M
Intangible Assets 150.0M 138.0M 86.3M 73.2M 44.0M 41.5M 43.5M 30.9M 32.6M 34.2M 22.9M 13.4M 14.3M 4.4M
Long Term Deferred Expenses 13.6M 5.8M -- -- -- -- -- -- -- -- -- -- -- --
Total Non Current Assets 4.3B 3.6B 2.9B 1.2B 622.0M 481.0M 375.0M 342.0M 279.0M 237.0M 181.0M 117.0M 104.0M 43.4M
Total Assets 5.8B 5.0B 4.0B 2.0B 1.5B 743.0M 561.0M 541.0M 412.0M 386.0M 289.0M 190.0M 185.0M 126.0M
Short Term Borrowings 123.0M 682.0M 915.0M 79.2M 18.5M 55.1M 50.1M 70.0M 45.0M 50.0M 30.0M 54.0M 60.0M 69.0M
Accounts Payable 713.0M 564.0M 589.0M 222.0M 99.9M 86.8M 44.9M 69.9M 64.0M 34.8M 22.9M 19.4M 23.2M 10.5M
Advance Receipts -- -- -- -- -- -- 688,500 1.1M 638,500 2.5M 1.0M 1.5M 396,200 1.6M
Contract Liabilities 17.0M 17.4M 12.8M 19.6M 17.6M 1.7M -- -- -- -- -- -- -- --
Total Current Liabilities 1.3B 1.6B 1.7B 389.0M 183.0M 162.0M 132.0M 165.0M 130.0M 141.0M 89.6M 102.0M 145.0M 107.0M
Long Term Borrowings 1.6B 638.0M 305.0M -- -- -- -- 15.0M 30.0M 40.0M 59.7M 13.3M -- --
Total Non Current Liabilities 1.8B 827.0M 468.0M 157.0M 108.0M 91.5M 60.0M 65.3M 71.3M 69.1M 85.2M 33.5M 19.6M 10.8M
Total Liabilities 3.1B 2.4B 2.1B 545.0M 291.0M 253.0M 192.0M 231.0M 201.0M 210.0M 175.0M 136.0M 165.0M 118.0M
Paid In Capital 250.0M 250.0M 158.0M 108.0M 108.0M 81.0M 81.0M 46.4M 45.9M 45.9M 45.9M 12.5M 10.0M 10.0M
Capital Reserve 1.2B 1.2B 603.0M 624.0M 588.0M 41.9M 41.9M 76.6M 53.0M 53.0M 53.0M 36.7M 10.5M --
Surplus Reserve 90.7M 78.4M 55.6M 37.7M 35.8M 22.6M 19.2M 14.0M 10.6M 8.8M 5.9M 1.8M 484,400 --
Retained Earnings 1.1B 1.1B 1.1B 721.0M 463.0M 344.0M 227.0M 173.0M 101.0M 68.5M 9.7M 3.1M -570,900 -2.2M
Minority Equity -14.8M -6.3M -1.3M 1.2M -- -- -- -- -- -- -- -- -- --
Equity Attributable 2.6B 2.6B 1.8B 1.5B 1.2B 490.0M 369.0M 310.0M 211.0M 176.0M 114.0M 54.1M 20.5M 7.8M
Total Equity 2.6B 2.6B 1.8B 1.5B 1.2B 490.0M 369.0M 310.0M 211.0M 176.0M 114.0M 54.1M 20.5M 7.8M
Line ItemFY 2025Dec 31, 2025FY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013FY 2012Dec 31, 2012
Cash From Sales 2.7B 2.3B 2.0B 1.2B 851.0M 360.0M 439.0M 354.0M 315.0M 301.0M 157.0M 175.0M 93.3M 48.4M
Tax Refunds Received 87.3M 93.9M 78.3M 58.4M 41.1M 22.1M 23.7M 23.5M 14.0M 11.9M 8.3M 5.5M 4.8M 185,800
Total Operating Cash Inflow 2.9B 2.5B 2.1B 1.3B 935.0M 436.0M 487.0M 390.0M 350.0M 317.0M 176.0M 185.0M 110.0M 60.4M
Cash Paid For Goods 2.2B 1.7B 1.4B 676.0M 652.0M 174.0M 175.0M 195.0M 162.0M 195.0M 82.7M 106.0M 42.4M 51.7M
Cash Paid To Employees 322.0M 271.0M 159.0M 118.0M 78.1M 54.5M 49.9M 39.4M 30.4M 23.4M 17.1M 14.5M 10.4M 7.2M
Taxes Paid 55.3M 93.4M 89.8M 55.8M 40.2M 46.2M 33.4M 31.5M 21.8M 17.2M 18.0M 9.4M 1.5M 1.4M
Total Operating Cash Outflow 2.8B 2.3B 1.8B 947.0M 839.0M 326.0M 305.0M 301.0M 244.0M 262.0M 140.0M 154.0M 68.4M 67.2M
Operating Cash Flow 105.0M 200.0M 301.0M 357.0M 95.7M 110.0M 181.0M 89.3M 106.0M 55.0M 35.3M 30.6M 41.2M -6.8M
Total Investing Cash Inflow 2.1M 3.6M 215.0M 172.0M 13.8M 1.2M 2.0M 176,800 985,700 325,700 30.9M 16.1M 2.5M 13.0M
Total Investing Cash Outflow 646.0M 934.0M 1.3B 514.0M 526.0M 75.0M 81.9M 63.9M 48.1M 58.8M 103.0M 23.1M 47.8M 8.0M
Investing Cash Flow -643.0M -930.0M -1.1B -342.0M -512.0M -73.8M -79.9M -63.8M -47.1M -58.5M -72.2M -7.0M -45.3M 5.0M
Cash From Borrowings 1.7B 1.8B 1.4B 112.0M 53.8M 76.0M 50.0M 70.0M 45.0M 80.0M 93.3M 67.3M 88.0M 102.0M
Dividends And Interest Paid 111.0M 183.0M 109.0M 60.3M 37.6M 2.9M 74.6M 4.6M 31.7M 8.1M 35.4M 20.1M 6.3M 5.4M
Debt Repayments 1.2B 1.5B 246.0M 51.1M 90.0M 86.0M 85.0M 55.0M 80.0M 66.7M 54.0M 60.0M 97.0M 69.6M
Total Financing Cash Inflow 1.7B 2.5B 1.4B 118.0M 650.0M 76.0M 56.0M 71.2M 45.0M 84.7M 143.0M 77.3M 109.0M 104.0M
Total Financing Cash Outflow 1.3B 1.7B 395.0M 111.0M 173.0M 97.1M 165.0M 66.1M 113.0M 78.0M 90.2M 90.6M 104.0M 103.0M
Financing Cash Flow 409.0M 781.0M 1.0B 6.5M 477.0M -21.1M -109.0M 5.0M -68.2M 6.7M 52.8M -13.3M 4.2M 575,100
Net Change In Cash -131.0M 62.5M 206.0M 27.1M 60.2M 12.0M -6.2M 29.8M -11.4M 3.4M 15.8M 10.3M 56,500 -1.2M
Ending Cash Balance 284.0M 415.0M 352.0M 147.0M 120.0M 59.7M 47.7M 53.8M 24.0M 35.4M 32.0M 16.1M 5.8M 5.8M
Capex 637.0M 924.0M 1.3B 456.0M 181.0M 72.6M 81.7M 63.4M 48.0M 58.8M 90.1M 19.4M 22.5M 8.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...